These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 28512002)

  • 21. Succinate promotes stem cell migration through the GPR91-dependent regulation of DRP1-mediated mitochondrial fission.
    Ko SH; Choi GE; Oh JY; Lee HJ; Kim JS; Chae CW; Choi D; Han HJ
    Sci Rep; 2017 Oct; 7(1):12582. PubMed ID: 28974722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
    Lu J; Tan M; Cai Q
    Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B).
    Offermanns S; Colletti SL; Lovenberg TW; Semple G; Wise A; IJzerman AP
    Pharmacol Rev; 2011 Jun; 63(2):269-90. PubMed ID: 21454438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxy-Carboxylic Acid Receptor Actions in Metabolism.
    Offermanns S
    Trends Endocrinol Metab; 2017 Mar; 28(3):227-236. PubMed ID: 28087125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Ketogenic Diet Improves Mitochondrial Biogenesis and Bioenergetics via the PGC1α-SIRT3-UCP2 Axis.
    Hasan-Olive MM; Lauritzen KH; Ali M; Rasmussen LJ; Storm-Mathisen J; Bergersen LH
    Neurochem Res; 2019 Jan; 44(1):22-37. PubMed ID: 30027365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91.
    Trauelsen M; Rexen Ulven E; Hjorth SA; Brvar M; Monaco C; Frimurer TM; Schwartz TW
    Mol Metab; 2017 Dec; 6(12):1585-1596. PubMed ID: 29157600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Succinate, increased in metabolic syndrome, activates GPR91 receptor signaling in urothelial cells.
    Mossa AH; Velasquez Flores M; Cammisotto PG; Campeau L
    Cell Signal; 2017 Sep; 37():31-39. PubMed ID: 28554536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and Pharmacological Properties of Silicon-Containing GPR81 and GPR109A Agonists.
    Geyer M; Baus JA; Fjellström O; Wellner E; Gustafsson L; Tacke R
    ChemMedChem; 2015 Dec; 10(12):2063-70. PubMed ID: 26459194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the GPR91 ligand succinate in hematopoiesis.
    Hakak Y; Lehmann-Bruinsma K; Phillips S; Le T; Liaw C; Connolly DT; Behan DP
    J Leukoc Biol; 2009 May; 85(5):837-43. PubMed ID: 19204147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment.
    Brown TP; Bhattacharjee P; Ramachandran S; Sivaprakasam S; Ristic B; Sikder MOF; Ganapathy V
    Oncogene; 2020 Apr; 39(16):3292-3304. PubMed ID: 32071396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell surface lactate receptor GPR81 is crucial for cancer cell survival.
    Roland CL; Arumugam T; Deng D; Liu SH; Philip B; Gomez S; Burns WR; Ramachandran V; Wang H; Cruz-Monserrate Z; Logsdon CD
    Cancer Res; 2014 Sep; 74(18):5301-10. PubMed ID: 24928781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of GPR81, the lactate receptor, from distant species identifies residues and motifs critical for GPR81 functions.
    Kuei C; Yu J; Zhu J; Wu J; Zhang L; Shih A; Mirzadegan T; Lovenberg T; Liu C
    Mol Pharmacol; 2011 Nov; 80(5):848-58. PubMed ID: 21862690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing.
    Sakurai T; Davenport R; Stafford S; Grosse J; Ogawa K; Cameron J; Parton L; Sykes A; Mack S; Bousba S; Parmar A; Harrison D; Dickson L; Leveridge M; Matsui J; Barnes M
    Eur J Pharmacol; 2014 Mar; 727():1-7. PubMed ID: 24486398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
    Laurenti G; Tennant DA
    Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IFNγ Induces DNA Methylation-Silenced GPR109A Expression via pSTAT1/p300 and H3K18 Acetylation in Colon Cancer.
    Bardhan K; Paschall AV; Yang D; Chen MR; Simon PS; Bhutia YD; Martin PM; Thangaraju M; Browning DD; Ganapathy V; Heaton CM; Gu K; Lee JR; Liu K
    Cancer Immunol Res; 2015 Jul; 3(7):795-805. PubMed ID: 25735954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GPR91, a critical signaling mechanism in modulating pathophysiologic processes in chronic illnesses.
    Li X; Xie L; Qu X; Zhao B; Fu W; Wu B; Wu J
    FASEB J; 2020 Oct; 34(10):13091-13105. PubMed ID: 32812686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The intracellular localization of enzymes in white-adipose-tissue fat-cells and permeability properties of fat-cell mitochondria. Transfer of acetyl units and reducing power between mitochondria and cytoplasm.
    Martin BR; Denton RM
    Biochem J; 1970 May; 117(5):861-77. PubMed ID: 4393782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The β-Hydroxybutyrate-GPR109A Receptor Regulates Fasting-induced Plasticity in the Mouse Adrenal Medulla.
    Gupta R; Wang M; Ma Y; Offermanns S; Whim MD
    Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35595517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual Properties of Lactate in Müller Cells: The Effect of GPR81 Activation.
    Vohra R; Aldana BI; Waagepetersen H; Bergersen LH; Kolko M
    Invest Ophthalmol Vis Sci; 2019 Mar; 60(4):999-1008. PubMed ID: 30884529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.